Skip to content
DataLookout
Menu

NCT06467526

Efficacy and Safety of Hydroxychloroquine in the Treatment of Sudden Sensorineural Hearing Loss

StatusRecruiting
PhasePhase 2
Primary completion (estimated)

At risk: Primary completion moved 7 months later.

Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 2 versions: 2 with changes below. See every version on ClinicalTrials.gov ↗

  1. Notable Primary completion pushed from May 31, 2026 to Dec 31, 2026 Show 5 more changesShow less
    • Recruitment opened
    • Eligibility criteria expanded, about 17 words
    • Study sites: 0 to 1
    • Start date changed from estimate of Jul 1, 2024 to Sep 10, 2024
    • Study description expanded, about 7 words
  2. Study First Submitted
  • Notable: the plan changed

Endpoints

Primary

Hearing improvement
Timeframe: from screening until 3 months

Secondary (2)

Word recognition score
Tinnitus severity

Arms and interventions

Hydroxychloroquine groupExperimental

Hydroxychloroquine with steroid

Control groupOther

Steroid only

Drugs: Hydroxychloroquine, Steroid

Sites

1 site in 1 country

  • Kaohsiung Chang Gung Memorial HospitalKaohsiung City, Taiwan